Fingerprint
Dive into the research topics of 'Professor Charles E. Geyer: Neoadjuvant therapy is becoming standard of care for HER2+ breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Professor Charles E. Geyer: Neoadjuvant therapy is becoming standard of care for HER2+ breast cancer
Charles E. Geyer
Research output: Contribution to journal › Editorial › peer-review
1
Scopus
citations